Community Magazine

New Shingles Vaccine and What It Means for CLL Patients

By Bkoffman
If you haven't had time to participate in our 2017 CLL Patient Survey, please consider doing it today. You can participate online or request a paper survey. Find out more here. If you've already participated, THANK YOU! We are hoping to capture as many voices of CLL as possible, so we can best understand the experience of patients.
You may have read in the news or on the online forums about the recent approval, both in the US and in Canada, of a new shingles vaccine, Shingrix, a killed herpes zoster (HZ) vaccine for adults over 50 years old. You can read more about shingles, the data that led to the specific indication, potential reimbursement issues and my commentary here.
Our next CLL Patient Education Forums will be taking place this Saturday 11/11 in Cleveland, OH.  I will be there and hope you can join me.
We look forward to seeing you there. After ASH 2017 we'll be in Seattle, WA and Bethesda, MD (plus more after the holidays). You'll hear the latest data about CLL and be able to ask questions of CLL Experts. See below for the full schedule, more information and to register. If you want a personal response, or just want to stay in touch, please email me at bkoffmanMD@gmail.com. I have no other way of contacting. Thanks. Stay strong. After all, we are all in this together. And please visit our website: http://cllsociety.org for the latest news and information.

Back to Featured Articles on Logo Paperblog

Magazines